Evaluation of Agreement Between CT Scan and 3D-DXA Measurements on the Lombar Spine
NCT ID: NCT03638674
Last Updated: 2022-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
120 participants
INTERVENTIONAL
2019-02-26
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysis of Bone Micro-Architecture as a Clinical Biomarker for Image-Based Fracture Risk Estimation.
NCT03463850
Bone Marrow Adiposity and Fragility Fractures in Postmenopausal Women
NCT03219125
Bone Microarchitectural Database Constitution From HR-pQCT Device in Clinical Situation Potentially Associated With Bone Loss
NCT02532439
Clinical Evaluation Of An X-Ray Bone Densitometer:Use Of DXA Technology For Precise Assessment Of Human Body Composition
NCT02965742
Open Access Database of Standing Full Body Radiographs in Asymptomatic Volunteers
NCT03076658
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2nd lumbar spine acquisition in same position
spine and hip STRATOS DR + 2nd lumbar spine acquisition in same position (with template)
DXA + CT
Two dual-energy X-ray scans + CT scan
2nd lumbar spine acquisition
spine and hip STRATOS DR + 2nd lumbar spine acquisition (no template)
DXA + CT
Two dual-energy X-ray scans + CT scan
2nd hip acquisition in same position
spine and hip STRATOS DR + 2nd hip acquisition in same position (with template)
DXA + CT
Two dual-energy X-ray scans + CT scan
2nd hip acquisition
spine and hip STRATOS DR + 2nd hip acquisition (without template)
DXA + CT
Two dual-energy X-ray scans + CT scan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DXA + CT
Two dual-energy X-ray scans + CT scan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient must be a member or beneficiary of a health insurance plan
* The patient is at least 18 years old
* The patient has been referred by a doctor for a PET/CT (Positron Emission Tomography-Computed Tomography) scan or a SPECT (Single Photon Emission Computed Tomography) scan in the Nuclear Medicine and Medical Biophysics Department of Nimes hospital or a bone scan including a SPECT/CT (single photon emission computed tomography coupled with a CT scan)
Exclusion Criteria
* The subject refuses to sign the consent
* It is impossible to give the subject informed information
* The patients is under judicial protection or state guardianship
* The patient is pregnant or breast feeding
* The subject has a observably serious scoliosis
* Subject has previously had spinal or hip surgery
* Subject weighs more than 200kg and/or is more than 2 meters tall by 5+65cm wide and 70cm diameter
* Patient uses an insulin pump or wears an insulin or morphine tubing or any attenuating equipment affecting the hips or lumbar spine
* Subject has already had an X-ray exam using a contrast product such as barium in the 7 days preceding the visit
* Subject having undergone γ radiation exam in the 15 days preceding the visit
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DMS Apelem
INDUSTRY
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Nimes
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LOCAL/2016/VB-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.